Gnanasakthy A, Russo J, Gnanasakthy K, Harris N, Castro C. A review of patient-reported outcome assessments in registration trials of FDA-approved new oncology drugs (2014-2018). Contemp Clin Trials. 2022 Sep;120:106860. doi: 10.1016/j.cct.2022.106860
Barnes TL, MacLeod S, Tkatch R, Ahuja M, Albright L, Schaeffer JA, Yeh CS. Cumulative effect of loneliness and social isolation on health outcomes among older adults. Aging Ment Health. 2022 Jul;26(7):1327-34. doi: 10.1080/13607863.2021.1940096
Tkatch R, Wu L, MacLeod S, Ungar R, Albright L, Russell D, Murphy J, Schaeffer J, Yeh CS. Reducing loneliness and improving well-being among older adults with animatronic pets. Aging Ment Health. 2021 Jul;25(7):1239-45. doi: 10.1080/13607863.2020.1758906
Bell TR, Hill NL, Bhargava S, Mogle J. Parental dementia and subjective memory impairment in the health and retirement study. Aging Ment Health. 2021 May;26(5):992-1000. doi: 10.1080/13607863.2021.1910790
Bhang I, Mogle J, Hill N, Whitaker EB, Bhargava S. Examining the temporal associations between self-reported memory problems and depressive symptoms in older adults. Aging Ment Health. 2020 Nov;24(11):1864-71. doi: 10.1080/13607863.2019.1647135
Mogle J, Hill N, Bhang I, Bhargava S, Whitaker E, Kitt-Lewis E. Time frame, problem specificity, and framing: the implicit structures of questions about memory in older adults. Aging Ment Health. 2020 Jan;24(1):56-62. doi: 10.1080/13607863.2018.1523882
John NM, Wright SJ, Gavan SP, Vass CM. The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review. Eur J Health Econ. 2019 Nov;20(8):1123-31. doi: 10.1007/s10198-019-01082-x
Ling W, Nadipelli VR, Ronquest N, Albright VA, Aldridge AP, Learned SM, Mehra V, Heidbreder C. Remission from chronic opioid use-studying environmental and socio-economic factors on recovery (RECOVER): study design and participant characteristics. Contemp Clin Trials. 2019 Jan;76:93-103. doi: 10.1016/j.cct.2018.11.015
Wilson MR, Bergman A, Chevrou-Severac H, Selby R, Smyth M, Kerrigan MC. Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom. Eur J Health Econ. 2017 Mar;19(2):229-40. doi: 10.1007/s10198-017-0879-5.
Vodicka E, Kim K, Devine EB, Gnanasakthy A, Scoggins JF, Patrick DL. Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007-2013). Contemp Clin Trials. 2015 Apr 18;43:1-9. doi: 10.1016/j.cct.2015.04.004
Gnanasakthy A, DeMuro C, Boulton C. Integration of patient-reported outcomes in multiregional confirmatory clinical trials. Contemp Clin Trials. 2013 May 1;35(1):62-9.
Beard SM, von Scheele BG, Nuki G, Pearson IV. Cost-effectiveness of febuxostat in chronic gout. Eur J Health Econ. 2013 May;Advance online publication.
Hareendran A, Gnanasakthy A, Winnette RM, Revicki D. Capturing patients' perspectives of treatment in clinical trials/drug development. Contemp Clin Trials. 2012 Jan;33(1):23-8.
Stull DE, Wiklund I, Gale R, Capkun-Niggli G, Houghton K, Jones P. Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD. Contemp Clin Trials. 2011 Nov 1;32(6):818-28.
Nguyen USDT, Rothman KJ, Demissie S, Jackson DJ, Lang JM, Ecker JL. Transfers among women intending a birth center delivery in the San Diego birth center study. J Midwifery Womens Health. 2009 Mar 1;54(2):104-10.
Doward L, Karim S, Ramanna G, Petit T, Burns A. Development of the Dementia Quality of Life questionnaire (D-QOL): uK version. Aging Ment Health. 2008 Jan;12(1):144-8.
Greiner W, Lehmann K, Earnshaw S, Bug C, Sabatowski R. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany. Eur J Health Econ. 2006 Dec 1;7(4):290-6.
Lehmann K, Radbruch L, Gockel HH, Neighbors D, Nuyts G. Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Duragesic) with controlled release morphine. Eur J Health Econ. 2002;3:111-9. doi: 10.1007/s10198-002-0097-6.